Our Projects

In October 2010 it was announced that over £200m would be invested by the UK government in a network of elite technology and innovation centres.

Cambridge Biomedical Campus is home to the world renowned Addenbrooke's Hospital, Cambridge University's School of Clinical Medicine, Cancer Research UK and other research institutes.

The Guy’s and St Thomas’ Charity is an independent, place-based foundation that works with Guy’s and St Thomas’ NHS Foundation Trust and others to improve the health of people in the London boroughs of Lambeth and Southwark.

MedCity was set up by the Mayor of London and the London Development Agency to oversee the promotion of the health sciences sector in London and the Greater South East.

The University of Warwick developed its science park in partnership through a joint venture company owned by the University of Warwick, Coventry City Council, Warwickshire County Council, and the West Midlands Enterprise Board since 1982.

Following the successful development of Citylabs, a 100,000 sq ft lab and office building alongside the Central Manchester NHS Hospital, Bruntwood sought to expand their holdings by delivering the next Life Sciences building and wanted to ensure it delivered laboratory space appropriate to market demand.

The University of Cambridge aspired to bring forward the East Forum project at their West Cambridge Campus. 

In March 2011 the UK government announced the award of £26 million to fund the further development of Norwich Research Park.

The University of Nottingham wanted to look at securing space and facilities to work alongside businesses working in the digital sector and asked its Innovation Park company to support the initiative – who in turn needed advice around likely business need and how best to build soft infrastructure that can support the work sustainably.

Cambridge Science Park is the oldest and one of the most successful science parks in Europe.

The University of Cambridge owned West Cambridge Campus is a 65 hectare site with outline permission for 170,000 sq m of academic, residential and commercial research development.

UK Property Fund MEPC had made significant investment at Granta Park in facilities and accommodation for research businesses, with a particular focus on the life sciences.

The West of Scotland Science Park has been developed by Scottish Enterprise, in part with private sector developers, over a period of about 20 years.

Tesco Pension Fund wanted to forward fund the laboratory and office building that had been pre-let to Abcam plc at the Cambridge Biomedical Campus.

Creative Places acted for Kadans Science Partner in the purchase of this strategic site in Cambridge, which forms a gateway to the city and Cambridge Science Park.

Scottish Enterprise is a public sector body responsible for identifying and exploiting the opportunities for economic growth in Scotland.

Cambridge Biomedical Campus is home to the world-renowned Addenbrooke's Hospital, Cambridge University's School of Clinical Medicine, Cancer Research UK and other research institutes.

Babraham Bioscience Technologies (BBT) are responsible for the development and management of the Babraham Research Campus near Cambridge, UK.

The London Borough of Sutton is in the process of bringing forward the London Cancer Hub, a proposed development of space for commercial R&D alongside the Institute of Cancer Research and the Royal Marsden Hospital.

Both Guy’s and St Thomas’ NHS Foundation Trust and King’s College London have been building commercial relationships with businesses that collaborate with them at the Guy’s Hospital Campus and building their infrastructure to support ever growing spin-out business activity.

Oxford Properties sought to build a portfolio of Life Sciences R&D real estate in UK and were keen to understand the dynamics and opportunity areas in the market.

Clearbell were looking to buy an office property for conversion into wet laboratories not too far from King’s Cross, a prime location for the growing Life Sciences sector in London.

The University of Cambridge has invested significantly in its campus on the western edge of Cambridge, where major academic departments including the Cavendish Laboratory and Engineering have globally important research facilities, alongside commercial R&D business. 

Having historically been involved in strategic discussions and instructions with a variety of stakeholders in Stevenage for several years, including GSK, the Stevenage Biosciences Catalyst and the Cell and Gene Therapy Manufacturing Catapult, it was evident that expanding occupiers in the ecosystem had pent up demand for space.

Kadans Science Partner wanted to continue their successful building of a UK Life Sciences portfolio and expand their holdings into the important Oxford market.

When the former Royal Eye Hospital in Manchester became vacant, due to the relocation of the Eye Hospital to new accommodation, the building’s owners Central Manchester University Hospitals NHS Foundation Trust needed to find a viable solution for its continued use which would support the Trust’s aims as an Academic Health Science Centre.

Derwent wanted to consider the Life Sciences options for this building in its redevelopment. Viability for this use, verses office redevelopment needed to be considered so as to conclude what to build.

The London Borough of Sutton is home to a globally significant cluster of excellence in cancer research and clinical care at the Royal Marsden Hospital and the Institute of Cancer Research (ICR).

The London Bioscience Innovation Centre was established in 2000 by the Royal Veterinary College as a direct response to the shortage of accommodation for Life Science activity in Central London.

Our client Scottish Enterprise has made significant investment in the BioQuarter development in Edinburgh, a new campus for biomedical R&D adjacent to the Edinburgh Royal Infirmary and University of Edinburgh Medical School.

Imperial College London is developing a world leading science and technology environment for knowledge creation, knowledge transfer, collaboration, innovation and enterprise at its new campus at Imperial West in White City.

BioCampus is a bio-manufacturing science park initiative that was instigated by Scottish Enterprise over ten years ago.

The South West of England Regional Development Agency (SWRDA) and the Universities of Bristol, Bath and West of England wished to develop a new science park in Bristol.

BA Pension Fund bought ‘The Ugly Brown Building’ redevelopment site in 2015, with plans to provide new office accommodation and a hotel for one of the principal occupiers in the location, Ted Baker.

The Wellcome Trust has developed the Genome Campus in Hinxton, Cambridgeshire to one of the foremost locations in the world for genomics research and big data analysis. 

The University of Leeds wanted to make a step change to its Innovation Centre initiative – not just moving the activity into a new building in a prominent position at the front of the University campus, city centre facing, but also moving it culturally to becoming a high profile gateway to research and innovation at the University. 

The University of Southampton had created one of the most successful, flourishing science parks in the country.

The BioData Innovation Centre was built by the Wellcome Trust at their Genome Campus in Hinxton, Cambridge.

Global investment fund Mitsui Fudosan and Developers Stanhope were selected by the British Library to deliver the extension to the library accommodation together with space for the Alan Turing Institute and commercial businesses.

Kadans Science Partner had the desire to invest into the UK, building on their excellent track record in delivering Life Sciences R&D real estate in Holland.

Manchester Science Park has a strong reputation within the UK science park movement for delivering property and support services to R&D businesses in the north-west.